Animal Drug Compounding Market worth US$ 155 billion by 2031 – Exclusive Report by Fact.MR

As stated in a new report by Fact.MR, North America and Europe will emerge as leading regional markets for animal drug compounding, while Asia Pacific will exhibit the fastest growth throughout the forecast period of 2021 to 2031. The global animal drug compounding market is projected to progress at a moderate CAGR over the next ten years.

Surging demand due for various animal drug compounding products such as CNS agents, GI drugs due to the increasing requirements within the pharmaceutical sector is bolstering the market growth. Rise in requirement for oral route of administration for animal drug compounding and demand for anti-infectives will rise the fastest, accelerating the animal drug compounding demand.

Request a report sample to gain comprehensive insights at

Key Takeaways from Market Study
  • High requirement for anti-infectives likely to be witnessed.
  • Oral and injectable segments to boost sales in terms of route of administration.
  • Companion animal segment to emerge lucrative across regions.
  • Capsule and suspension forms of dosage to augment demand growth.
  • The United States remain a huge market for animal drug compounding.
  • Germany to exhibit hegemony in Europe’s market for animal drug compounding.
  • Asia Pacific to emerge the fastest-growing region for manufacturers of animal drug compounding products.
  • The United Kingdom, China, South Korea, France, and Canada to remain high-potential markets throughout the forecast period.
“The market is subject to steady growth owing to increase in requirement for anti-inflammatory and anti-infective drugs such as tramadol, metronidazole, and others,”

says a Fact.MR analyst.

animal drug compounding market

Demand for Companion Animal Drugs Surging

Drug compounding products are highly required for companion animals such as dogs, cats, and others. With increase in inclination towards domestication of such animals, suppliers of animal drug compounding products are experiencing surge in demand around the globe.

According to a report titled “U.S. Pet Ownership Statistics”, published by the American Veterinary Medical Association, the percentage of households owning dogs in the United States is 38.4, while 25.4% of U.S. people have cats as their pets. This gives a glimpse of the rising demand for various animal drug compounding products around the globe, such as GI drugs, CNS agents, and others.

Request More Information about Report Methodology

Competitive Landscape

Key players operating in the animal drug compounding market profiled by Fact.MR includes Wedgewood Pharmacy, Triangle Compounding Pharmacy, Davis Islands Pharmacy, Custom Med Compounding Pharmacy, Central Compounding Center South, Wellness Pharmacy of Cary, Caringbah Compounding Pharmacy, Millers Pharmacy, Smith’s Pharmacy, Specialist Compounding Pharmacy Pvt. Ltd., and Tache Pharmacy. New product launches along with strategic mergers & acquisition remains the core strategy for the market players to thrive in the industry.

For instance, on 14th November 2020, Chewy Pharmacy’s Compounding Ingredients announced the launch of compounding medications for pets.

Also, in October 2020, Wedgewood Pharmacy announced the acquisition of Wildlife Pharmaceuticals Inc. and its subsidiary, ZooPharm, a compounding pharmacy that provides veterinary-anesthesia and pain-management medications to care for non-domestic species, captive exotic breeds and companion animals.

Get More Insights-

Who is Winning in this Space?

The global animal drug compounding market is highly competitive in nature. In order to sustain its leading positions, key players in this field are bringing in a wider variety of quality products.

For instance,

  • Davis Islands Pharmacy recently launched its new range of products such as GABAPENTIN VET SUSPENSION, FLUOXETINE TRANSDERMAL CREAM, DES CAPSULES, and others.
  • Custom Med Compounding Pharmacy launched its new range of anti-infective therapy solution, transdermal medications, and others, a couple of years back.

Explore Fact.MR’s Coverage on the Healthcare Domain

NGS Data Analysis Market: A new report of Fact.MR envisages the global market for NGS data analysis to record a spectacular growth during the forecast period (2017-2026).

Oncology Small Molecule Drugs Market: Fact.MR’s “Oncology Small Molecule Drugs Market – Global Market Insights 2019-2029,” provides a detailed analysis on the global oncology small molecule drugs market. Size of the oncology small molecule drugs market has been analyzed in a comprehensive way and is presented in terms of value (US$ Mn).

Glaucoma Diagnostics Market: The global Glaucoma Diagnostics market is anticipated to show significant growth as Optical Coherence Tomography (OCT) Imaging Systems, Corneal Pachymeters, Tonometers offers greater advantage over tradition procedures for diagnosis of glaucoma.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website:
Research Insight:
Press Release: